MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1210/jc.2012-3072

Медицинская библиотека · The Journal of clinical endocrinology and metabolism · 2013

A comprehensive study of clinical, biochemical, radiological, vascular, cardiac, and sleep parameters in an unselected cohort of patients with acromegaly undergoing presurgical somatostatin receptor ligand therapy.

Annamalai Anand K, Webb Alison, Kandasamy Narayanan, Elkhawad Maysoon, Moir Samantha, Khan Fakhar, Maki-Petaja Kaisa, Gayton Emma L, Strey Christopher H, O'Toole Samuel, Ariyaratnam Shaumya, Halsall David J, Chaudhry Afzal N, Berman Laurence, Scoffings Daniel J, Antoun Nagui M, Dutka David P, Wilkinson Ian B, Shneerson John M, Pickard John D, Simpson Helen L, Gurnell Mark

Клиническое исследованиеСравнительное исследованиеСтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

CONTEXT: Attainment of safe GH and IGF-1 levels is a central goal of acromegaly management.

OBJECTIVE

The aim of this study was to determine the extent to which reductions in GH and IGF-1 concentrations correlate with amelioration of radiological, metabolic, vascular, cardiac, and respiratory sequelae in a single unselected patient cohort.

STUDY

DESIGN

This was a prospective, within-subject comparison in 30 patients with newly diagnosed acromegaly (15 women and 15 men: mean age, 54.3 years; range, 23-78 years) before and after 24 weeks of lanreotide Autogel (ATG) therapy.

RESULTS

Reductions in GH and IGF-1 concentrations and tumor volume were observed in all but 2 patients (median changes [Δ]: GH, -6.88 μg/L [interquartile range -16.78 to -3.32, P = .000001]; IGF-1, -1.95 × upper limit of normal [-3.06 to -1.12, P = .000002]; and pituitary tumor volume, -256 mm(3) [-558 to -72.5, P = .0002]). However, apnea/hypopnea index scores showed highly variable responses (P = .11), which were independent of ΔGH or ΔIGF-1, but moderately correlated with Δweight (R(2) = 0.42, P = .0001). Although systolic (P = .33) and diastolic (P = .76) blood pressure were unchanged, improvements in arterial stiffness (aortic pulse wave velocity, -0.4 m/s [-1.2 to +0.2, P = .046]) and endothelial function (flow mediated dilatation, +1.73% [-0.32 to +6.19, P = .0013]) were observed. Left ventricular mass index regressed in men (-11.8 g/cm(2) [-26.6 to -1.75], P = .019) but not in women (P = .98). Vascular and cardiac changes were independent of ΔGH or ΔIGF-1 and also showed considerable interindividual variation. Metabolic parameters were largely unchanged.

CONCLUSIONS

Presurgical ATG therapy lowers GH and IGF-1 concentrations, induces tumor shrinkage, and ameliorates/reverses cardiac, vascular, and sleep complications in many patients with acromegaly. However, responses vary considerably between individuals, and attainment of biochemical control cannot be assumed to equate to universal complication control.

Для цитирования: Annamalai Anand K, Webb Alison, Kandasamy Narayanan, Elkhawad Maysoon, Moir Samantha, Khan Fakhar, Maki-Petaja Kaisa, Gayton Emma L, Strey Christopher H, O'Toole Samuel, Ariyaratnam Shaumya, Halsall David J, Chaudhry Afzal N, Berman Laurence, Scoffings Daniel J, Antoun Nagui M, Dutka David P, Wilkinson Ian B, Shneerson John M, Pickard John D, Simpson Helen L, Gurnell Mark. A comprehensive study of clinical, biochemical, radiological, vascular, cardiac, and sleep parameters in an unselected cohort of patients with acromegaly undergoing presurgical somatostatin receptor ligand therapy.. The Journal of clinical endocrinology and metabolism. 2013. DOI: 10.1210/jc.2012-3072.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.